Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Phathom Pharmaceuticals, Inc. | StockGist | StockGist

Companies
PHAT
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings PHATSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Phathom Pharmaceuticals, Inc.

Filed Mar 12, 2026

Accepted Mar 12, 2026, 4:46 PM ET

CIK 0001783183

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Phathom Pharmaceuticals, Inc.

Person Type

OO

CUSIP: 71722W107

Amendment History

3 filings

SCHEDULE 13G
Original
Viewing
Mar 12, 20260001104659-26-027124
SCHEDULE 13G/A
Amendment 1
Nov 5, 20240001137774-24-000254
SCHEDULE 13G/A
Amendment 2
Latest
Jan 27, 20260001104659-26-007000

Recent Filings

Phathom Pharmaceuticals, Inc.1 months ago

Phathom Pharmaceuticals, Inc.1 months ago

Phathom Pharmaceuticals, Inc.2 months ago

Phathom Pharmaceuticals, Inc.2 months ago

Phathom Pharmaceuticals, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice